Document Detail


Management of hemophilia in developing countries.
MedLine Citation:
PMID:  11284184     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Coagulation disorder are common in India. In the absence of any epidemiological studies it is expected that there are at least 50,000 severe hemophilics in our country. The factor concentrates are not easily available in developing countries which poses a major problem while managing severe bleeding episodes in these patients. Various strategies which could be useful while managing these cases in developing countries have been reviewed.
Authors:
R Kashyap; V P Choudhry
Related Documents :
20549434 - Capitalizing on multi-element interactions through balanced nutrition--a pathway to imp...
1855494 - Regulation of in-place asbestos-containing material.
12347834 - Pocket guide to mda indicators.
22150604 - Canine hip dysplasia: reviewing the evidence for nonsurgical management.
12397904 - Ethics in child and adolescent forensic psychiatry.
7355324 - Semantics of general medicine.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Indian journal of pediatrics     Volume:  68     ISSN:  0019-5456     ISO Abbreviation:  Indian J Pediatr     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-04-03     Completed Date:  2001-04-26     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0417442     Medline TA:  Indian J Pediatr     Country:  India    
Other Details:
Languages:  eng     Pagination:  151-7     Citation Subset:  IM    
Affiliation:
Department of Hematology, All India Institute of Medical Sciences, New Delhi-110029, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Developing Countries
Emergencies
Factor IX / therapeutic use
Factor VIII / therapeutic use
Hemophilia A / complications,  diagnosis,  genetics,  therapy*
Hemophilia B / complications,  diagnosis,  genetics,  therapy*
Hemostatics / therapeutic use
Humans
Male
Musculoskeletal Diseases / etiology,  rehabilitation
Chemical
Reg. No./Substance:
0/Hemostatics; 9001-27-8/Factor VIII; 9001-28-9/Factor IX

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Massive blood transfusion.
Next Document:  Blood support for pediatric surgery.